News

White paper

API market dynamics for penicillins during COVID-19 crisis

20 August 2020, Munich - Prices for penicillins increased by 14-20 % during the first half of 2020 with prices for some penicillin APIs “shooting up” more than 40 %. Governments worldwide have undertaken efforts to decrease reliance on API imports from Asia...

White paper

Considered a “breakthrough drug” against COVID-19, Dexamethasone API prices are likely to rise in the near future

18 June 2020, Munich - British scientists from Oxford University published a study about Dexamethasone demonstrating positive effects on patients requiring ventilation due to a corona infection...

White paper

COVID-19 could trigger “backshoring” of pharmaceutical manufacturing from India and China

14 May 2020, Munich - Primarily driven by lower prices for APIs manufacturing has mainly moved to India and China. The corona crisis could become a turning point for the pharmaceutical industry...

White paper

Chloroquine and hydroxychloroquine experience significant price increase due to corona virus crisis

29 April 2020, Munich - Shortly after the outbreak of the corona crisis, scientists started to test existing drugs as potential remedies. Two malaria drugs received particular attention and widespread media coverage...

White paper

If existing drugs prove effective against CoViD-19 – how do we prevent shortages?

22 March 2020, Munich - Remedies against HIV, Malaria or high blood pressure are under evaluation in the fight of COVID-19. If proven effective...

Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany – In November 2019, QYOBO will attend the 30th edition of the world’s largest pharmaceutical...

Events

ECP Summer Summit

25/26 September 2019, Düsseldorf – QYOBO attends the 2nd European Chemistry Partnering (ECP) Summer Summit at Henkel’s Headquarter in Düsseldorf. Beyond connecting with industry leaders...

Events

WECONOMY, Berlin

12 September 2019, Berlin, Germany – WECONOMY (Wissenfabrik, UnternehmerTUM, Handelsblatt) recognizes QYOBO as “one of the 10 most...

Events

BASF

Out of more than 100 startups worldwide, BASF selected QYOBO as its partner “to understand our customers’ needs and map...

White paper

API market dynamics for penicillins during COVID-19 crisis

White paper

Considered a “breakthrough drug” against COVID-19, Dexamethasone API prices are likely to rise in the near future

White paper

COVID-19 could trigger “backshoring” of pharmaceutical manufacturing from India and China

White paper

Chloroquine and hydroxychloroquine experience significant price increase due to corona virus crisis

White paper

If existing drugs prove effective against CoViD-19 – how do we prevent shortages?

Events

CPhI Worldwide

Events

ECP Summer Summit

Events

WECONOMY, Berlin

Events

BASF

Solution

Company

Support

Copyright 2020 QYOBO. All rights reserved